Qiagen, Exosome Diagnostics Expand Partnership to MDx Development | GenomeWeb

NEW YORK (GenomeWeb News) — Qiagen and Exosome Diagnostics said today that they have expanded their collaboration to develop non-invasive in vitro molecular diagnostics.

The diagnostics will be based on Exosome's proprietary methods for purifying nucleic acids from biofluid exosomes and other microvesicles with Qiagen's sample prep technologies to create "cost-effective, easy-to-use, and automated sample-to-results workflows," the companies said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.